[{"NetIncomeLoss_1_Q2_USD":-43668000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":1718000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":36.87,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":10405000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":0.0,"Depreciation_2_Q2_USD":306000.0,"PaymentsToAcquireInvestments_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":49.75,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":757992.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":275174000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":107382000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":46318000.0,"TreasuryStockShares_0_Q2_shares":1994198.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":13417778.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":13417778.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":168000.0,"TreasuryStockValue_0_Q2_USD":54998000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":28268533.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":703000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":201734000.0,"Assets_0_Q2_USD":280461000.0,"ShareBasedCompensation_2_Q2_USD":14335000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4261000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":36.45,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1990000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":272098000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":3270000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":36.87,"EarningsPerShareBasic_2_Q2_USD":-5.16,"EarningsPerShareBasic_1_Q2_USD":-1.67,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":26109089.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":26225073.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":23000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":9000.0,"AccountsReceivableNetCurrent_0_Q2_USD":21854000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":26000.0,"InterestPayableCurrent_0_Q2_USD":1400000.0,"AccruedInvestmentIncomeReceivable_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":876151.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":53028000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":25074000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":51158000.0,"IncreaseDecreaseInInventories_2_Q2_USD":7578000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-134603000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-43668000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-22182000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":219186000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1920000.0,"Liabilities_0_Q2_USD":584771000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":48637000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":40659000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8584000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-136934000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":21293000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":26109089.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":26225073.0,"OtherCostAndExpenseOperating_2_Q2_USD":3584000.0,"OtherCostAndExpenseOperating_1_Q2_USD":1800000.0,"LiabilitiesCurrent_0_Q2_USD":82644000.0,"AccountsPayableCurrent_0_Q2_USD":29353000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":440000.0,"InterestExpense_2_Q2_USD":19269000.0,"InterestExpense_1_Q2_USD":11144000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":219186000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9770000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2836000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":108000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":10405000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":722534000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":182745.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":10371000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":970000.0,"NetIncomeLoss_2_Q2_USD":-134603000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":0.0,"AmortizationOfFinancingCosts_2_Q2_USD":804000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3875614.0,"EarningsPerShareDiluted_1_Q2_USD":-1.67,"OperatingIncomeLoss_2_Q2_USD":-115357000.0,"OperatingIncomeLoss_1_Q2_USD":-32533000.0,"InventoryNet_0_Q2_USD":23714000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3930000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":28.06,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.52,"LiabilitiesAndStockholdersEquity_0_Q2_USD":280461000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12419000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2346000.0,"OperatingExpenses_2_Q2_USD":163994000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":3325000.0,"OperatingExpenses_1_Q2_USD":73192000.0,"StockholdersEquity_0_Q2_USD":-304310000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":1057000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":201734000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":56000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3875614.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2948732.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-971872000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-85776000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":9466000.0,"EarningsPerShareDiluted_2_Q2_USD":-5.16,"OtherLiabilitiesNoncurrent_0_Q2_USD":1290000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":4046000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]